Market Cap

Cell Source, Inc. Market Capitalization:

$38,778

USD as of July 1, 2023

business Cell Source, Inc. Company Profile

Cell Source, Inc. Main Stock Listing

OTC: CLCS

Market Capitalization History of Cell Source, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Cell Source, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $14.1 M -69.92%
Jan. 1, 2022 $46.9 M -36.92%
Jan. 1, 2021 $74.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Cell Source, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Cell Source, Inc. has the following listings and related stock indices.


Stock: OTC: CLCS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.